- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION an CDC
- Monovalent XBB.1.5 vaccine shows 51% protection against COVID hospitalization University of Minnesota Twin Cities
- Fall COVID-19 vaccine cut illness risk by half overall The Globe and Mail
- The fall COVID-19 shot’s effectiveness, and other respiratory virus news this week The Globe and Mail
- Latest booster reduces adults’ risk of moderate or severe COVID by more than half Medical Xpress